Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963943 | Vaccine | 2015 | 12 Pages |
Abstract
Rift Valley fever virus (RVFV) is a mosquito-borne virus, and is the causative agent of Rift Valley fever (RVF), a zoonotic disease characterised by an increased incidence of abortion or foetal malformation in ruminants. Infection in humans can also lead to clinical manifestations that in severe cases cause encephalitis or haemorrhagic fever. The virus is endemic throughout much of the African continent. However, the emergence of RVFV in the Middle East, northern Egypt and the Comoros Archipelago has highlighted that the geographical range of RVFV may be increasing, and has led to the concern that an incursion into Europe may occur. At present, there is a limited range of veterinary vaccines available for use in endemic areas, and there is no licensed human vaccine. In this review, the methods available for diagnosis of RVFV infection, the current status of vaccine development and possible implications for RVFV emergence in Europe, are discussed.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Karen L. Mansfield, Ashley C. Banyard, Lorraine McElhinney, Nicholas Johnson, Daniel L. Horton, Luis M. Hernández-Triana, Anthony R. Fooks,